Dexamethasone Export Market Intelligence: India's 808 Suppliers Shipping to 176 Countries — TransData Nexus 2026

Q: Who are the top dexamethasone exporters from India?

The top dexamethasone exporters from India are: 1. DR.REDDY'S LABORATORIES LTD — $40.8M (22.5% market share); 2. DR REDDYS LABORATORIES LIMITED — $29.6M (16.3% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $20.6M (11.4% market share); 4. SAKAR HEALTHCARE LIMITED — $13.9M (7.7% market share); 5. FREDUN PHARMACEUTICALS LTD — $6.7M (3.7% market share). Together they account for 61.6% of India's total dexamethasone export value.

Q: What is the total export value of dexamethasone from India?

The total export value of dexamethasone from India is $181.4M USD, recorded across 8,777 shipment transactions from 808 active exporters to 176 destination countries. The average shipment value is $20.7K.

Q: Which countries import dexamethasone from India?

India exports dexamethasone to 176 countries worldwide. The top importing countries are: UNITED STATES (62.7% share, $113.7M), ETHIOPIA (8.0% share, $14.6M), NIGERIA (6.2% share, $11.3M), RUSSIA (3.6% share, $6.5M), AUSTRALIA (1.5% share, $2.7M). These five markets account for 82.0% of total export value.

Q: What is the average price of dexamethasone exports from India?

The average unit price for dexamethasone exports from India is $26.04 USD per unit, with prices ranging from $0.00 to $23333.33 depending on formulation, packaging, and order volume. The total market is valued at $181.4M across 8,777 shipments.

Q: Which ports handle dexamethasone exports from India?

The primary ports for dexamethasone exports from India are SAHAR AIR (13.8% of shipments), SAHAR AIR CARGO ACC (INBOM4) (12.8% of shipments), NHAVA SHEVA SEA (INNSA1) (8.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.8% of shipments), DELHI AIR (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of dexamethasone?

India is one of the world's leading exporters of dexamethasone due to its large base of 808 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports dexamethasone to 176 countries, demonstrating 90% global market coverage.

Q: What certifications do Indian dexamethasone exporters need?

Indian dexamethasone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import dexamethasone from India?

There are 2,257 registered buyers importing dexamethasone from India, spread across 176 countries. The repeat buyer rate is 50.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top dexamethasone supplier from India?

DR.REDDY'S LABORATORIES LTD is the leading dexamethasone exporter from India with a market share of 22.5% and total export value of $40.8M across 46 shipments. The top 5 suppliers together control 61.6% of total export value.

Suresh Sormare

Dexamethasone

India Pharmaceutical Trade Intelligence

$181.4M808 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES62.7%India → ETHIOPIA8.0%

ImportsBRAZIL → India$30.7B CHINA → India$42.9M

#1 Buyer: DR REDDYS

Dexamethasone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Dexamethasone to the World

Between 2022 and 2026, India exported $181.4M worth of dexamethasone across 8,777 verified shipments to 176 countries — covering 90% of world markets in the Corticosteroids segment. The largest destination is UNITED STATES (62.7%). DR.REDDY'S LABORATORIES LTD leads with a 22.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Dexamethasone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Dexamethasone export data snapshot — $181.4M · 808 exporters · 176 countriesTransData Nexus · Indian Customs Data

Top Dexamethasone Exporters from India

808 active exporters · Ranked by export value

View all 808 →

Top Dexamethasone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	DR.REDDY'S LABORATORIES LTD	$40.8M	46	1	22.5%
2	DR REDDYS LABORATORIES LIMITED

Top Countries Importing Dexamethasone from India

176 destination markets · Ranked by import value

All 176 countries →

Top Countries Importing Dexamethasone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$113.7M	62.7%
2	ETHIOPIA	$14.6M	8.0%
3	NIGERIA	$11.3M	6.2%
4	RUSSIA	$6.5M	3.6%
5	AUSTRALIA	$2.7M	1.5%
6	KENYA	$2.7M	1.5%
7	CANADA	$2.3M	1.3%
8	SRI LANKA	$1.8M	1.0%
9	KAZAKHSTAN	$1.8M	1.0%
10	UZBEKISTAN	$1.6M	0.9%

UNITED STATES is India's largest dexamethasone export destination, absorbing 62.7% of total exports worth $113.7M. The top 5 importing countries — UNITED STATES, ETHIOPIA, NIGERIA, RUSSIA, AUSTRALIA — together account for 82.0% of India's total dexamethasone export value. The remaining 171 destination countries collectively receive the other 18.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Dexamethasone to India?

18 origin countries · Total import value: $30.8B

India imports dexamethasone from 18 countries with a combined import value of $30.8B. The largest supplier is BRAZIL ($30.7B, 8 shipments), followed by CHINA and FRANCE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Dexamethasone to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	BRAZIL	$30.7B	8	99.7%
2	CHINA	$42.9M	10	0.1%
3	FRANCE	$36.4M	3	0.1%
4	IRELAND	$6.9M	14	0.0%
5	NETHERLANDS	$1.5M	2	0.0%
6	UNITED STATES	$886.1K	297	0.0%
7	SWITZERLAND	$353.0K	9	0.0%
8	GERMANY	$201.7K	25	0.0%
9	BELGIUM	$59.6K	12	0.0%
10	IRAQ	$30.4K	1	0.0%

Showing top 10 of 18 origin countries

BRAZIL is the largest supplier of dexamethasone to India, accounting for 99.7% of total import value. The top 5 origin countries — BRAZIL, CHINA, FRANCE, IRELAND, NETHERLANDS — together supply 100.0% of India's dexamethasone imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Dexamethasone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, dexamethasone is approved for various indications, including the treatment of severe COVID-19 cases. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for dexamethasone, reflecting its established presence in the market. Notably, the FDA has not issued any import alerts specific to dexamethasone products from India as of March 2026, indicating compliance with U.S. regulatory standards. Given that 62.7% of India's dexamethasone exports are directed to the U.S., it is imperative for Indian exporters to maintain stringent adherence to FDA regulations to ensure uninterrupted market access.

2EU & UK Regulatory Framework

In the European Union, dexamethasone-containing products have secured marketing authorizations through the European Medicines Agency (EMA). For instance, Ozurdex received EU-wide approval on July 27, 2010, for treating macular edema and non-infectious uveitis. Similarly, Neofordex was authorized on March 16, 2016, for multiple myeloma treatment. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, ensuring consistent regulatory requirements. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for market entry, necessitating that Indian manufacturers adhere to these standards to facilitate exports to the EU and UK.

3WHO Essential Medicines & Global Standards

Dexamethasone has been included in the WHO Model List of Essential Medicines since 1977, underscoring its critical role in healthcare. The WHO has prequalified dexamethasone solutions for injection, produced by three manufacturers, for treating COVID-19, affirming its safety and efficacy. Additionally, dexamethasone formulations are standardized across major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality benchmarks for global distribution.

4India Regulatory Classification

In India, dexamethasone is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on dexamethasone, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with international regulatory requirements, facilitating the smooth export of pharmaceutical products.

5Patent & Exclusivity Status

Dexamethasone is off-patent globally, enabling the production and export of generic versions without infringement concerns. This status has led to a competitive market with multiple manufacturers supplying dexamethasone, contributing to its widespread availability and affordability.

6Recent Industry Developments

In April 2025, the WHO reiterated its recommendation for using dexamethasone in severe COVID-19 cases, emphasizing its life-saving potential. This endorsement has sustained global demand for dexamethasone, particularly in countries grappling with COVID-19. Additionally, the EMA approved a new indication for Sarclisa in November 2024, involving its combination with dexamethasone for treating newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant. This approval may influence demand dynamics for dexamethasone in the EU market.

These developments highlight the evolving regulatory and market landscape for dexamethasone, necessitating that Indian exporters remain vigilant and adaptable to maintain and expand their global market share.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Dexamethasone

Retail & reference prices across 9 markets vs. India FOB export price of $26.04/unit

Global Price Benchmark for Dexamethasone across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.85	USD	According to the FDA Orange Book, dexamethasone is available as a generic medication, contributing to its affordability.
United Kingdom	$0.09	GBP	The NHS Drug Tariff lists dexamethasone tablets, ensuring standardized pricing across the UK.
Germany	$0.11	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates medication prices, including dexamethasone, to maintain affordability.
Australia	$0.11

Supply Chain Risk Assessment — Dexamethasone

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India is a leading producer of Active Pharmaceutical Ingredients (APIs), including dexamethasone. However, the Indian pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and intermediates essential for API production. This dependency exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and production disruptions in China.

Recent events have highlighted the vulnerability of this reliance. In March 2026, the closure of the Strait of Hormuz due to escalating conflicts disrupted global shipping routes, affecting the timely import of critical raw materials from China to India. This disruption underscores the need for diversification in sourcing strategies to mitigate such risks.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of dexamethasone account for 61.6% of total exports, with DR. REDDY'S LABORATORIES LTD leading at a 22.5% share. This high concentration poses a single-source risk, as any operational or regulatory issues affecting these key suppliers could significantly impact global supply.

To address such vulnerabilities, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of APIs and reduce dependency on imports. While this initiative is a positive step, its effectiveness in diversifying the supplier base and mitigating concentration risks remains to be fully realized.

Access Complete Dexamethasone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 8,777 transactions across 176 markets.

Request Demo View Pricing

Frequently Asked Questions — Dexamethasone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top dexamethasone exporters from India?

The leading dexamethasone exporters from India are DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 11 others. DR.REDDY'S LABORATORIES LTD leads with 22.5% market share ($40.8M). The top 5 suppliers together control 61.6% of total export value.

What is the total export value of dexamethasone from India?

The total export value of dexamethasone from India is $181.4M, recorded across 8,777 shipments from 808 active exporters to 176 countries. The average shipment value is $20.7K.

Which countries import dexamethasone from India?

India exports dexamethasone to 176 countries. The top importing countries are UNITED STATES (62.7%), ETHIOPIA (8.0%), NIGERIA (6.2%), RUSSIA (3.6%), AUSTRALIA (1.5%), which together account for 82.0% of total export value.

What is the HS code for dexamethasone exports from India?

The primary HS code for dexamethasone exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Dexamethasone

Dexamethasone

Top Dexamethasone Exporters from India

Top Countries Importing Dexamethasone from India

Who Supplies Dexamethasone to India?

Quick Facts

Related Corticosteroids

Related Analysis

Need Details?

Regulatory Landscape — Dexamethasone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Dexamethasone

Supply Chain Risk Assessment — Dexamethasone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Dexamethasone Trade Intelligence

Frequently Asked Questions — Dexamethasone Exports from India

Who are the top dexamethasone exporters from India?

What is the total export value of dexamethasone from India?

Which countries import dexamethasone from India?

What is the HS code for dexamethasone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of dexamethasone exports from India?

Which ports handle dexamethasone exports from India?

Why is India a leading exporter of dexamethasone?

What certifications do Indian dexamethasone exporters need?

How many buyers import dexamethasone from India?

What is the market share of the top dexamethasone exporter from India?

Analysis Methodology